De novo molecular drug design benchmarking

Area of Science:

• Computational chemistry and cheminformatics
• Machine learning in drug discovery
• Deep learning for molecular design

Background:

• De novo molecular design is a rapidly advancing field crucial for identifying novel drug candidates.
• Deep neural networks (DNNs) are increasingly utilized for generating new molecular structures.
• Standardized methods for comparing and validating these DNN models are necessary.

Purpose of the Study:

• To review and analyze recently developed benchmarking methods for de novo molecular design.
• To assess the potential applications and limitations of these benchmarking tools.
• To propose future directions for validating molecular design models.

Main Methods:

• Review of prominent benchmarking methodologies: Fréchet ChemNet Distance, GuacaMol, and Molecular Sets (MOSES).
• Comparative analysis of the strengths and weaknesses of each method.
• Discussion of their utility in the context of deep neural network-based molecular design.

Main Results:

• Fréchet ChemNet Distance, GuacaMol, and MOSES offer valuable frameworks for evaluating molecular generation models.
• Each method presents unique advantages in assessing different aspects of molecular design.
• Current methods require further refinement and validation for comprehensive model assessment.

Conclusions:

• Benchmarking is critical for advancing de novo molecular design using deep learning.
• Continued development and validation of methods like Fréchet ChemNet Distance, GuacaMol, and MOSES are essential.
• Standardized evaluation will accelerate the discovery of novel therapeutics through AI-driven molecular design.